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Abstract: In oral biology, tissue engineering aims at regenerating functional tissues through a series
of key events that occur during alveolar/periodontal tissue formation and growth, by means of
scaffolds that deliver signaling molecules and cells. Due to their excellent physicochemical properties
and biomimetic features, nanomaterials are attractive alternatives offering many advantages for
stimulating cell growth and promoting tissue regeneration through tissue engineering. The main aim
of this article was to review the currently available literature to provide an overview of the different
nano-scale scaffolds as key factors of tissue engineering for alveolar bone regeneration procedures.
In this narrative review, PubMed, Medline, Scopus and Cochrane electronic databases were searched
using key words like “tissue engineering”, “regenerative medicine”, “alveolar bone defects”, “alveolar
bone regeneration”, “nanomaterials”, “scaffolds”, “nanospheres” and “nanofibrous scaffolds”.
No limitation regarding language, publication date and study design was set. Hand-searching
of the reference list of identified articles was also undertaken. The aim of this article was to give a
brief introduction to review the role of different nanoscaffolds for bone regeneration and the main
focus was set to underline their role for alveolar bone regeneration procedures.
Keywords: scaffolds; nanomaterials; tissue engineering; regenerative medicine; alveolar
bone regeneration
1. Introduction
The reconstruction and augmentation of the alveolar bone is a complex and challenging field for the
maxillofacial and periodontal surgeon. The crucial aim of the therapies in this field is mainly increasing
the bone mass in patients who have lost this tissue as a result of a consequence of several conditions
such as periodontal disease, aging, osteoporosis, trauma, neoplastic pathology and reconstructive
surgery or as a result of congenital defects [1].
At present auto-transplantation from a patient’s extra-oral or intra-oral donor site is accepted
as the gold standard and is the most frequently used method [2]. The critical limitations of this
conventional approach are donor site morbidity, inadequate blood supply of graft tissue, associated
pain and limited supply. For these reasons, autologous grafting is usually reserved for a restricted
number of cases [2,3].
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Alternative sources for bone grafts include allografts (grafts originating from another individual
of the same species) and xenografts (grafts originating from different species such as bovine or porcine).
However, these substitutes also have some certain disadvantages such as the possibility of immune
rejection and pathogen transmission from donor to host [2,3].
Another strategy for bone grafts is the use of synthetic alloplasts made from polymers, ceramics
or metals. Alloplasts represent some disadvantages including non-optimal integration with the native
tissue at the site of the defect and the potential failure due to fatigue or infection caused during
implantation. In addition to these, their applications are limited at locations of high stress or mechanical
load [2,3].
Owing to the drawbacks and limitations of bone grafts, over the last few decades, several
novel approaches involving tissue engineering and regenerative medicine (TE/RM) have emerged
as alternatives to conventional treatments. The fundamental concept underlying TE/RM was to use
scaffolds alone or in combination with growth factor, cell and/or gene delivery to form a so-called
“tissue engineering construct,” that stimulates tissue repair and/or regeneration [2–5].
In brief, the four crucial factors that must be considered with TE/RM are:
• Cells, which represent the fundamental structural unit of any tissue,
• A matrix such as “scaffolds”, as framework material supporting the growth of cells to form a fully
organized tissue,
• Biological factors like growth factors (GF) and bone morphogenetic proteins (BMPs) to guide
cellular activity and tissue formation,
• Vascularization to provide oxygen and nutrients for the cell metabolism, and to remove catabolic
waste products [6,7].
Current limitations in bone TE/RM strategies are the impaired cellular differentiation, inadequate
synthesis of extrinsic factors essential for an effective osteogenesis and, most importantly, insufficient
mechanical strength and physicochemical properties of the conventional scaffolds [7]. Conventional
scaffolds combined with growth factors and cells do not always achieve successful bone regeneration
in clinical settings, generally due to the limited capability of controlling framework degradation as
well as delivery of biological factors and drugs [6,8,9].
The focus of this review was to give a brief introduction to the nanoscaffolds in TE/RM and to
underline the role of different scaffolds in successful tissue formation for bone regeneration. The main
aim of this literature-based article is to provide an overview of the different nanoscale scaffolds as key
factors of the tissue-engineering paradigm, used for alveolar bone regeneration.
In order to find articles pertinent to this narrative review, PubMed/Medline, Scopus and Cochrane
electronic databases were searched using key terms such as “tissue engineering”, “regenerative
medicine”, “alveolar bone defects”, “alveolar bone regeneration”, “nanomaterials”, “scaffolds”,
“nanospheres” and “nanofibrous scaffolds”. No limitation regarding study design, publication date
and language was set. A hand search through the references of the identified articles and previous
reviews was also undertaken. The last electronic search was performed on 3 December 2019.
1.1. Importance of Scaffolds in TE/RM
Scaffold material plays a key role in tissue regeneration, as it provides a micro-environment
suitable for cell adhesion, proliferation and differentiation. In general, an ideal scaffold material should
be biocompatible, have a controllable degradation and appropriate physico-chemical features in order
to simulate the extracellular matrix (ECM) structure of the original tissues [7]. It should be able to
balance various combinations of materials with specific functions by means of engineered surface, cell
encapsulation and controlled release of chemicals [6,9]. Additionally, it should be able to endorse and
control peculiar events occurring at the cellular and tissue level [10].
In scaffold based tissue engineering, the scaffold is expected to perform several functions. It should
provide adequate mechanical strength and stiffness to replace the mechanical properties of the missing
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or the injured tissue [6,11]. Most importantly, a successful scaffold should stimulate not only the early
ingrowth of new tissue, but also the progressive maturation and remodeling by providing adequate
support and morphology [12]. Its design should also take into account degradation kinetics and
physico-chemical features [6,11].
1.2. Nanotechnology
One thousand nm is equal to 1 micrometer (µm) and nanoparticles are smaller than 100 nanometers
(nm). Nanomaterials compared with bulk materials possess features like quantum size, macroscopic
quantum tunneling, as well as small size effects, resulting in altered physiochemical properties [7].
Current areas of research in nanotechnology for tissue regeneration are as follows:
i. Nanoparticle-based techniques for delivering bioactive molecules,
ii. Nanoparticle-mediated cells tagging and targeting,
iii. Nanoparticle-based scaffold manufacturing [7].
Additionally, the half-life and distribution of nanoparticles can be affected by their size.
Their surface properties can determine their stability and their localization in the tissues [7]. A decreased
size in nanomaterial particles is beneficial in terms of stiffness, effective surface area and area-to-volume
ratio [7]. The charge of the nanoparticles is also another important factor affecting the internalization
of nanosized particles into different target cells [7].
In oral biology, nanotechnology applications are mainly focused on augmentation procedures
for bone tissue regeneration and enhancement of osseointegration of oral implants [7]. Natural bone
itself is constituted by a highly organized extracellular matrix (ECM) in a nanometric scale, and the
application of nanoscaffolds can represent an intrinsic advantage for tissue engineering regeneration
procedures of the musculoskeletal apparatus [8,13]. Nanomaterials can overcome the main problems
encountered with the current scaffolds used for bone regeneration such as: Inadequate mechanical
strength, instability of growth factors released and impaired cellular differentiation [7,10].
1.3. Rationale of Nanotechnology Scaffolds in Tissue Engineering
Advanced materials play a crucial role in promoting the bench-to-bedside translation of tissue
engineering technologies [14,15]. Direct application of therapeutic substances may be affected by
some limitations of the conventional scaffold materials including non-specific targeting, insufficient
physiological stability and low cell membrane permeability. Usually, supra-physiological doses are
needed to compensate for the poor pharmacokinetics of such agents, which in return increase the
potential risk of adverse effects [7]. Currently, nanotechnology has allowed the production of structures
having the same size as the naturally occurring tissues and has opened a new era for TE/RM [8,16].
Nanoscaffolds can be produced so as to be extremely similar to tissue-specific ECM. The reduced
size of the nanoparticles permits a fast response to external stimuli coming from the environment, like
ultrasounds, magnetic fields, pH and iX-ray exposure.
Nanoscaffold materials may be used to deliver drugs, genetic material or biological factors in a
controlled way, both systemically and locally [8]. Nanoscaffolds can stabilize the bioactive agents by
means of encapsulation or surface attachment, promoting molecule internalization, targeting their
delivery from cells and allowing to control biological factor release at the intended target [7]. Controlled
and sustained delivery by nanoparticles mainly depends on their reduced size and related high specific
surface area [17]. Thus they may represent stimulus-sensitive delivery vehicles for chemically or
biologically active substances, which will provide a triggered delivery as a response to an external
stimulus [7,16,17].
Nanoscaffolds have a considerable drug loading capability, high mobility of drug loaded particles,
and efficient in vivo reactivity toward nearby tissues [17]. They can be used for labeling cells, in order
to enable continuous cell tracking and monitoring [8,16]. Additionally, nanoparticles can provide
enhanced osseointegration, osteoconduction and osteoinduction [16].
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1.4. Nanofibrous Scaffold Systems
Fibrous nanoscaffolds are extremely-thin uninterrupted fibers with a short diffusional path, a
considerable surface area to unit mass ratio and high porosity. The porous structure of the nanofibrous
drug delivery systems is highly interconnected and represents an adequate substrate for cell adhesion
and transport of nutrients. One of the limitations of these systems is the initial burst release phenomenon,
which depends on the large surface area and the short diffusional path.
Fibrous nanoscaffolds, besides their role as drug carriers, provide mechanical strength. There had
been worries that drug incorporation into the nanofibers might impair the mechanical features of
the same nanofibers [8]. As an example for a solution to this problem, Ionescu et al. developed a
microsphere-laden fibrous nanoscaffold structure in which the microspheres were to deliver drugs,
while the nanofibers only worked as an engineered scaffold [18].
1.5. Nanosphere Scaffold Systems
Nanospheres can deliver drugs, growth factors or genetic material [7]. The advantages of
nanospheres over conventional monolithic bulk scaffolds can be listed as follows:
• Mechanically weak scaffolds in load-bearing applications may be reinforced by the adjunct of
nanospheres as cross-linking agents,
• The porosity of the materials constituting traditional scaffolds may be significantly enhanced, by
adding spheres like porogen. Increased porosity means allowing interior tissue infiltration into
the scaffold,
• Nanospheres can stimulate the creation of apatite crystals and the following mineralization of
hydrogels through the release of the corresponding minerals, so that self-hardening biomaterials
adapted to the regeneration of bone tissue can be produced.
• Injectable and/or moldable materials can be developed thanks to the spherical nature of some
nanomaterials, so that their application is possible by means of minimally invasive surgery [17].
1.6. Classification of Nanoparticle (NP) Materials
Nanoparticles can be classified as inorganic (Figure 1) and organic nanoparticles (Figure 2).
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1.6.1. Inorganic NPs
Synthetic Polymers
Synthetic polymers have some advantages, such as sufficient supply, easy fabrication, easy
adaptation, high safety profile and reasonable costs. Additionally, they have adjustable physiochemical
and morphological features, which are valuable for wide-scale production and application [19,20].
The most common synthetic polymers for biomedical applications are poly-α-hydroxyesters
(poly-glycolic acid (PGA), poly-lactic acid (PLA), poly-lactic-glycolic acid (PLGA) and poly-caprolactone
(PCL)) [20]. However, there are also disadvantages of poly-α-hydroxyesters, which can be listed as
follows: (i) Hydrophobicity, which causes failure of loading hydrophilic drugs or molecules and poor
cell adhesion, (ii) degradation by autocatalysis, which causes unpredictable degradation behavior,
(iii) an acidic degradation product, which leads to denaturation of bioactive proteins and inflammatory
tissue response, and (iv) low capacity of loading therapeutic agents, which limits their penetration into
the polymer network [20,21].
Various combinations of PLGA/PLLA/PEG/PCL were tested by several researchers with promising
results for alveolar bone regeneration applications [1,22–24].
• Dendrim rs
i are synthetic polymers with branching treelike structures. They are biocompatible
and biodegradable with uniform morphology. They have a high number of surface functional groups,
which makes them suitable for several applications [16,25]. Dendrimers can cause an improvement on
drug solubility [16,26] and are mostly used for targeted drug delivery reasons [16,27]. However, they
have a few disadvantages, like cytotoxicity and possible poor drug retention inside the branches of the
dendrimer [16].
Ceramic NPs
Ceramic materials are “synthethic crystalline, solid, inorganic non-metallic materials” [28].
Bioceramics include bioactive glass, bioactive glass–ceramic, calcium phosphate groups and
alumina [16,29,30].
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Bioceramics possess certain advantages like biocompatibility, nontoxicity and dimensional
stability [29]. They are added to the scaffolds to improve their structural properties and delivery
performance. Many ceramic materials such as calcium phosphate groups and mineral trioxide
aggregate materials have been used and are currently in use for bone regeneration procedures [16].
Bioactive glass nanoscaffold was investigated and was reported to be beneficial for formation of
new alveolar bone tissue [31].
• Calcium Phosphate (CP) Groups
Normal bone tissue is composed of 30% w/v organic collagen fibers and 70% inorganic matter,
mainly CP crystals. The latter represents a model for mimicking natural bone material at the
macro- and nanoscale level [7]. For this reason, CP nanoparticles (nano-tricalcium phosphate (nTCP)
and nano-hydroxyapatite (nHA)) have been the most commonly applied materials for bone tissue
regeneration [32].
CP has many favorable properties such as similarity to the inorganic portion of natural bone tissue,
biocompatibility, biosafety, osteoconductivity, low cost and ease of manufacturing. The drawbacks
are poor regulation of drug delivery and degradation rate [20,33]. However, when CP is used as a
single component, it might represent some limitations due to its poor mechanical features and very low
toughness. In order to overcome such drawbacks, researchers recently introduced composite scaffolds
composed of nTCP/nHA plus further biological materials or synthetic polymeric materials [33].
Several applications of nanoHA [34–39] and nanoTCP [40,41] combinations were investigated in
the literature and were reported as successful for alveolar bone tissue regeneration.
• Mineral Trioxide Aggregate (MTA)
MTA is prepared by bismuth oxide reaction, and is composed of tricalcium aluminate, tricalcium
silicate, dicalcium silicate and calcium sulfate dehydrate [42,43]. During hydration, MTA releases
Ca2+ and OH ions, which increases pH in order to neutralize the acidic metabolites produced by
macrophages and osteoclasts. Nanoscale particle sized tricalcium aluminate may increase bone
regeneration, inflammatory response and foreign body reactions [43].
Silica NPs
Silica, either itself or as a coating of other compounds, has been used for applications in the
biomedical field, like imaging and drug delivery [16]. According to their application purposes,
silica nanoparticles can be synthesized as bulk particles, core/shell silica NPs and mesoporous silica
nanoparticles (MSNPs) [16]. In particular, MSNPs have attracted the attention of researchers for
applications of controlled release. MSNPs can be synthesized in different ways to obtain particles with
various dimensions and physical properties. MSNPs have unique pore structure, high surface area
and large pore volume. Additionally, because of their honeycomb-like porous structure, they are able
to encapsulate and absorb a number of biomolecules [16,44,45].
The typical advantages of silica nanoparticles are their uniform morphology, biocompatibility and
chemical stability. Their disadvantage is their variable toxicity [16].
Metallic NPs
Metallic NPs are biocompatible materials with reduced cytotoxicity. Their functionalization is
easy; however, they need long term cytotoxicity testing and their coating is advised [16]. In biomedical
applications, gold NPs are considered as the safest and the most commonly utilized among other
metallic NPs. Gold NPs can be synthesized as spheres, rods or cages and they can be applied in areas
such as drug delivery, biosensing, bioimaging and photothermal therapy [16,46,47].
Combinations of gold and silver nanoparticles with chitosan for alveolar bone regeneration were
reported for gold [48] and silver [22] with successful outcomes for enhanced mineralization and
implant osseointegration.
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Magnetic NPs
In biomedical applications, nickel, iron, cobalt and their oxides may be used as magnetic
nanoparticles for drug delivery, three-dimensional cell organization, cell tracking, imaging procedures
and as biosensors [16,49]. Some magnetic nanoparticles offer super paramagnetic properties with
long-lasting and non-invasive tracking possibility. However, magnetic nanoparticles are cytotoxic and
coating is required due to the safety concerns for overcoming their cytotoxicity and for producing
biocompatible magnetic NPs [16].
1.6.2. Organic Nanoparticles
Liposomes
Liposomes are vesicles composed of bilayers of phospholipids [50]. Their properties are affected by
their lipid size, surface charge, composition and preparation method [16]. Liposomes are biodegradable,
stimuli responsive and can be incorporated with hydrophilic/hydrophobic drugs [16,51]. They are
mainly used in drug delivery and imaging [52]. They are the most clinically tested nanosystems,
with several commercialized formulations [51]. However, their rapid clearance from circulation and
scale-up issues might represent some disadvantages [16,51].
Natural Polymeric NPs
Natural polymers are biocompatible and biodegradable materials with bulk physical properties.
They are divided mainly as proteins and polysaccharides [53] and can be listed as collagen, alginate,
fibrin, gelatin and chitosan [17]. Due to their intrinsic biocompatibility and biodegradability, natural
polymers are very important for bone tissue engineering procedures [54]. The synthesis methods
can be flexible and polymer chains can show a wide diversity of composition and properties [53].
Generally they have high drug loading capability, but the scale-up issues might represent some
disadvantages [16,53].
• Collagen
Collagen is the most frequently tested natural polymer since the ECM of the natural bone
is mainly composed of collagen. It has excellent biocompatibility, optimal biodegradability and
negligible immunogenicity [17,55]. The limitations of the collagen can be listed as weak mechanical
stability, possible denaturation on processing and the intrinsic risk of causing immune reactions and/or
transmitting infectious agents. As an alternative solution, instead of collagen extracted from animals,
recombinant collagen was proposed for tissue engineering procedures [17].
• Gelatin
Gelatin is a denatured form of collagen with similar beneficial biological properties and limitations.
Gelatin degradation is controllable by tailoring the crosslinking procedures. The existing presence of
functional groups additionally allow functionalization by chemical transformation [17].
• Chitosan
Chitosan has many advantageous biological and physicochemical properties. It is biocompatibile,
antibacterial and its production is easy. Various studies have tested chitosan as a factor and/or drug
delivery system for pharmaceutical and tissue engineering applications [5,17].
Chitosan nanomaterial was tested by researchers with different combinations of nanoparticles
such as PLGA/bioactive glass [1], PCL/Sr-doped calcium phosphate [56], PLGA/silver [22] and gold [48]
for alveolar bone regeneration procedures with successful results in favor of alveolar bone regeneration.
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• Alginate
Alginates are biocompatible, hydrophilic, non-immunogenic and cost effective materials.
Their intrinsic features can induce in vivo calcification without the use of any additives and they are
suitable for a number of tissue engineering and drug delivery applications [17]. However their rather
slow degradation when implanted in bone defects is poorly controllable and they do not have cell
attachment sites for osteoblast anchorage [17].
Carbon
• Carbon Nanotubes
Carbon nanotubes (CNTs) are carbon allotropes with a long cylindrical structure. They might be
single-walled or multi-walled graphitic hollow tubular structures. They have mechanical and chemical
stability with optimum electrical properties. However, their good chemical stability might represent a
drawback for the covalent functionalization process. Carbon materials are added to the composite
scaffolds, in order to reinforce the structural properties [16].
Carbon nanotubes are effective on bone tissue regeneration as they promote cell proliferation
and osteogenic differentiation [57]. Several carbon nanomaterials like CNTs, graphene oxide (GO),
fullerenes, carbon dots (CDs), nano-diamonds and their derivatives were successfully tested as a
scaffold for bone tissue engineering [57].
• Graphene and Its Derivates
Graphene is a film monolayer one-atom-thick, with a honeycomb-like structure made of carbon
atoms, and arranged in a two-dimensional hexagonal structure [58]. Nanomaterials of the graphene
family include a great variety of graphene derivatives such as, graphene oxide (GO), reduced graphene
oxide (rGO) and graphene nanosheets [59,60]. Graphene and its derivatives represent advantageous
mechanical, electrochemical and physical properties such as, small size, large surface area, thermal
stability, electrical conductivity and mechanical strength. Additionally, graphene materials may be
functionalized and combined with different biomaterials and biomolecules, such as small molecules,
polymers or nanoparticles, by means of covalent or non-covalent interaction [50–61]. Graphene
materials are favorable for cell differentiation, proliferation and osteogenic differentiation. Additionally
they are biocompatible and represent antibacterial properties. However, the behavior of graphene is
dependent on its size, surface functionalization and its coating [59–61]. Biomedical applications of
graphene oxide can produce adverse effects mostly dependent on the dose and time. Currently, the
cytotoxicity of the GO material represents a challenging situation for clinical applications. The quality
of graphene plays a major role since the presence of impurities can cause undesired events [62].
Interactions between body and GO are still being investigated for in vivo applications and it is most
likely that their primary clinical applications shall be the ones for topical use or short-time transient
implantations [63].
GOs are able to enter into cytoplasm and nuclei. They can induce cell membrane damage and
apoptosis. GO can induce lung diseases by causing severe toxicity. GOs also stay for a long time
in kidneys since they are cleaned in the kidney by a very complex process [64]. Further studies are
lacking in the literature to explore their toxicity and effect on cells/tissues.
Graphene oxide combined with silk fibroin [65,66], GO-coating of titanium implants [67] and
GO-coating of collagen membranes [60,61] for guided bone regeneration were investigated by various
researchers. The results showed that these applications can improve cell proliferation and osteogenic
differentiation with success.
1.6.3. Composite Scaffolds
Inspired by the natural organic/inorganic composition of bone, different organic and/or inorganic
particle combinations were tested as composite scaffolds that increase the advantages and decrease
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the drawbacks of each component [17]. In order to overcome the disadvantages of a single particle,
strategies of different composite scaffold designs containing diverse materials have been developed by
many researchers [68].
Combining nHA with polymers of high molecular weight was evaluated to overcome the
disadvantages of a single material. PLA [19], PLGA [69], collagen [70], polyamide [71], coralline [72],
chitosan and PCL [73] have been combined with nHA and were found to improve scaffold
biocompatibility as well as mechanical strength. As an example for bone regeneration, several
studies have shown that the combination of nHA and collagen scaffolds has favorable mechanical
properties [19,70]. Collagen fiber provides an osteoinductive and absorbable scaffold for infiltration
of osteoblast cells. However, the nonabsorbable nHA can reduce this effect. For this reason, the
percentage of nHA and collagen in composite materials play a crucial role for tissue regeneration [19].
1.7. Manufacturing Methods to Fabricate Scaffolds
Strategies of scaffold designs utilizing particles can be listed as follows: (i) Particles as different
single components embedded into matrices, solid polymers, hydrogels or calcium phosphate cements,
(ii) particles combined into blocks for fabrication of scaffolds, (iii) haphazard packing, (iv) rapid
prototyping and self-assembling scaffolds (assembly driven by electrostatic, magnetic interactions or
hydrophobic interactions) [17].
Various methods have been developed to produce scaffolds with porous properties for bone
regeneration, such as freeze-drying [74], gas foaming [75], salt leaching [76], phase transformation [77],
sponge replication [78], electrospinning [79] and additive manufacturing methods such as 3D printing
(selective laser sintering (SLS), stereolithography, laser assisted printing, inkjet printing and extrusion
printing) [32,68,80].
The sol-gel phase, co-precipitation as well as chemo-mechanical techniques have been utilized for
nHA production [81]. However, these procedures are complex with high cost and poor reproducibility.
Additionally, the manufacturing variables, the low-yield end-products and high byproducts are difficult
to control, and the produced nHA is different from the biological HA in terms of physicochemical
properties [81].
1.8. Biphasic and Multiphasic Scaffolds
The nanoparticles have many limitations such as a high agglomeration rate and an uneven
distribution pattern. Biphasic and multiphasic preparations might partially overcome the limitations
of single-phase biomaterials by improving the bioactivity and biocompatibility [32] since they have the
ability to combine different material compositions and physical structures [82–84].
The rationale of utilizing multiphasic/biphasic scaffolds in oral science mostly depends on the
expectations from an ideal scaffold. An ideal scaffold should have various functions, such as the
support for cell colonization, migration, differentiation and growth. The design should also take
into account suitable physical and physicochemical properties together with degradation kinetics.
Multiphasic scaffolds are needed for an appropriate control of the spatiotemporal events for periodontal
tissue regeneration since they can allow compartmentalized tissue healing [82,83]. Manufacturing of
multiphasic nanoscaffolds for periodontal tissue engineering can be divided into three approaches:
(i) Bilayered occlusive membrane + bone compartment [84,85], (ii) compartmentalized biphasic
scaffolds [86–89] and (iii) compartmentalized triphasic scaffold [90]. In vitro and in vivo investigations
have reported promising results for biphasic/multiphasic scaffold designs. However, the methods still
need to be refined for future clinical applications.
1.9. Three-Dimensional (3D) Porous Scaffolds
Three-dimensional porous scaffolds have been developed and tested in many tissues, including
bone, cartilage, skin, muscle and vasculature [17]. The importance of 3D porous scaffolds comes from
their ability to simulate extracellular matrices, which can sustain cellular activity. They can provide a
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pool of bioactive signaling molecules through a sustained release to the natural environment. In this
way, they might regulate cell function and trigger tissue repair [17].
1.10. Three-Dimensional Bio-Printing
Three-dimensional bio-printing (3D additive manufacturing) is a precise layering of biomaterials,
biochemical substances and living cells, with spatial control of the positioning of each component [91].
Tissue bio-printing strategies include inkjet, micro-extrusion and laser-assisted bio-printing.
Three-dimensional printing is one of the hot topics in TE/RM and nanomaterials play a crucial
role in this manufacturing method [92,93]. The major challenge in these technologies is to provide
multiple cell types and micro-architecture of extracellular matrix (ECM) in an adequate resolution to
reproduce biological function [92,93].
In periodontal regeneration, the main challenge is the scaffold design, which might mimic
the periodontal tissue nature and organization. While 3D bio-printing may help to solve this
challenge, the long-term success of these applications mostly depends on the properties of the current
biomaterials [82,94].
1.11. Influence of Magnetic Fields on Biological Systems
Magnetism might play a significant role in the control of cell responses. A magnetic field can be
applied to cells externally or internally; cells can be embedded in a scaffold material with magnetic
properties [95]. Yun et al. investigated the additional effects of the outer static magnetic field (SMF)
with magnetic polycaprolactone nanocomposite scaffold for bone regeneration. According to the
results of this experiment, the combination of external and internal magnetism can be advantageous
for new bone formation [95].
2. Nanoscaffold Applications for alveolar Bone Regeneration
In TE/RM, one of the major research topics is to create bioconstructs that can integrate with the
in vivo tissues [10]. Current systems represent limitations such as restricted diffusion and uneven
cell-matrix distribution. In order to overcome limitations of the current materials, during the last years
different types of scaffolds and bioreactors have been designed and tested [10]. The regeneration of oral
tissues is very challenging [96] and nanomaterials might represent a great potential for future TE/RM
applications of various craniofacial and oral defects. The most frequently investigated nanomaterials for
oral tissues can be listed as nanofibers, nanoparticles, nanosheets, nanotubesand nanospheres. Recently,
the multi-layer nanoscaffolds for oral tissue regeneration were also tested by researchers [97,98].
In general, nanomaterials have excellent physiochemical properties and biomimetic features for
enhancing cell growth and tissue regeneration [96,97]. Nanomaterials, due to their size, can have an
effective control of the release rate of the each agent upon matrix degradation. Furthermore, they
can be used for delivery of therapeutic agents in alveolar bone and tooth regeneration. Nanofibers
represent an ideal environment for cell migration due to their similarity to extracellular matrices
and their high porosity. In addition, nanotubes and nanoparticles might enhance the chemical and
mechanical features of the scaffold, increase cell migration and proliferation, and tissue regeneration [96].
While the application of nanomaterials in TE/RM is still in its infancy phase with several limitations
to be addressed, the recent results of investigations indicate their potential role for future oral tissue
engineering applications [93].
Three fabricating modes exist for TE/RM scaffolds: Growth factor-scaffold, cell-scaffold and cell
growth factor-scaffold. In cell-scaffold, and cell growth factor-scaffold materials, cells are inserted on a
biocompatible scaffold, in order to proliferate into the scaffold and to remodel the natural environment
by secreting ECM. Biomaterials in periodontal tissue engineering are mainly growth factor-scaffold,
used as the carrier of exogenous growth factors. The main challenge is the necessity to provide an
adequate number of seeded cells integrated with the scaffold material in vitro and implanted into a
defect position [96,99].
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There is a huge number of experimental studies reported in the literature, searching for the best
nanoscaffold material for various periodontal tissue regeneration applications. Ogawa et al. [41] tested
nano-ß-TCP/collagen loaded with fibroblast growth factor-2 (FGF-2) on periodontal wound healing.
In the study, nano-ß-TCP scaffold, nano-ß-TCP scaffold loaded with FGF-2 and non-coated collagen
scaffold were implanted into one-wall infrabony defect models. nano-ß-TCP scaffold was fabricated
by surface coating of collagen scaffold with nanosize ß-TCP dispersion. According to the four week
post-surgery histological results, nano-ß-TCP scaffold loaded with FGF-2 displayed nearly five-times
greater periodontal tissue repair when compared with the collagen scaffold [41].
Xue et al. [22] produced nanoparticles of chitosan, PLGA and silver (Ag) for investigating
the optimal combination ratio for mineralization of periodontal membrane cells, and periodontal
tissue regeneration. The antibacterial properties of each nanoparticle were also evaluated. Different
combination ratios of nPLGA and chitosan were tested. According to the results, single nanoparticles
did not show any cytotoxicity and were able to enhance cell mineralization. Additionally, chitosan
and nAg showed antibacterial properties, while nAg limited cell proliferation. The 3:7 ratio of
nPLGA/chitosan and 50 µg/mL nAg was the optimal proportion [22].
Hydrogels are soft materials with (3D) polymer structure, water-absorbability and
adjustable physical and chemical properties [100]. Natural and synthetic hydrogels composed
of micro-/nanostructures have been shown to imitate the chemical and physical properties of
natural ECM for bone and periodontal tissue regeneration [37–101]. Gelatin can be modified by
methacryloyl (methacrylamide and methacrylate) side groups and the final product is GelMA [84].
Gelatin methacrylate (GelMA) is a biocompatible and photocrosslinkable hydrogel. Chen et al. [37]
tested fabrication of GelMA/nanohydroxylapatite microgel arrays using a photocrosslinkable method.
The group evaluated the regeneration and osteogenic proliferation of human periodontal ligament stem
cells (hPDLSCs) encapsulated in microgels. According to the results GelMA/nHA microgels (10%/2%
w/v) enhanced periodontal tissue regeneration. Since GelMA/nHA microgels enhanced hPDLSCs
proliferation and osteogenic differentiation in vitro and supported bone regeneration in vivo [37].
In recent years, researchers proposed and tested graphene-based nanomaterials for oral tissue
engineering because of the many advantageous properties and antibacterial capacities of the
graphene [60,61,102].
Sowmya et al. [1] tested a scaffold system for the regeneration of oral tissues (periodontal ligament,
cementum and alveolar bone) in a rabbit study [1]. The structure of the scaffold consisted of three
layers. For bone tissue a layer of chitosan/PLGA/nano-sized bioactive glass layer enriched with PRP,
for periodontal ligament a layer of chitosan/PLGA with the adjunct of fibroblast growth factor 2
(FGF-2), and finally for cementum a layer of chitosan/PLGA/nano-sized bioactive glass layer loaded
with cementum protein 1 (CEMP1). According to the histological and tomographic evaluation results,
new alveolar bone formation and complete periodontal healing was obtained in three months [1].
Zhang et al. [103] tested the incorporation of growth factors in nanomaterial-based silk fibroin
scaffolds in a dog study for tissue regeneration. Nanomaterial-based silk fibroin scaffolds loaded with
BMP-7 and/or platelet derived growth factor (PDGF)-ß adenovirus were used to test tissue regeneration.
According to the results, the scaffolds loaded with BMP-7 mainly enhanced alveolar bone regeneration,
while the scaffolds incorporated with PDGF-ß adenovirus produced a partial regeneration of the
periodontal ligament. The combination of growth factors created a synergistic effect showing up to
two times greater alveolar bone, periodontal ligament, and cementum formation, as compared with
each factor alone [103].
Vaquette et al. [40] tested PCL and ß–TCP for periodontal ligament and alveolar bone regeneration.
The scaffold design was composed of a flexible electrospun component for the periodontal ligament
section and a fused deposition modeled component for the bone section. Cell sheet technology was
utilized to manufacture biphasic scaffolds additively. While the results were promising with increased
mechanical stability of the cell sheets and mineralization, the bone section did not provide sufficient
ectopic bone proliferation [40].
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Rasperini et al. [104] tested an individualized custom-made 3D-biomanufactured scaffold for
regeneration of a periodontal osseous defect in a clinical study. For this purpose, a customized scaffold
containing PCL powder and HA was produced by using selective laser sintering technology, according
to the computed tomography scan of the patient’s defect. While the scaffold became exposed after
12 months, which led to failure, the results of this study are promising in terms of further research [104].
Nanomaterials seem to be promising for alveolar bone regeneration applications as they mostly
provide favorable results, as listed in Table 1. However, the decreased size of nanomaterials can
cause some potential problems. Nanomaterials possess sizes close to biological molecules, peptides,
deoxyribonucleic acid and viruses. Thus, they can provoke adverse events by moving throughout the
body, depositing in target organs (liver, lungs, kidney, heart and spleen), penetrating cell membranes
and staying in the mitochondria [105–108]. Manganese oxide, titanium dioxide, aluminum oxide, zinc
oxide and silver might accumulate and elicit harmful responses [109]. The brain is partly shielded
by the blood–brain barrier, but the nanoscale size of these materials might cause them to cross this
barrier or they might penetrate through the olfactory and sensory nerves. The biological toxicity of
nanomaterials is thought to be induced by their oxidative properties [110,111] and further research
should be conducted to evaluate and develop a science-based risk evaluation of the nanomaterials [109].
Table 1. Nanoscaffold applications for alveolar bone regeneration.
Material Reference Outcome
3 layer chitosan/PLGA/nano-sized
bioactive glass Sowmya et al. [1]
Complete periodontal healing and new
alveolar bone deposition after three months
GO-coating of collagen membranes Radunovic et al. [60] Favourable on promoting osteoblasticdifferentiation process
GO-coating of collagen membranes De Marco et al. [61]
Improved biocompatibility of collagen
membranes on in vitro human primary
gingival fibroblast model
PCL containing ß–TCP Vaquette et al. [40]
Enhanced mechanical stability of the cell
sheets, and mineralization. However,
ectopic bone ingrowth was not sufficient
nano-ß- TCP/collagen scaffolds Ogawa et al. [41]
nano-ß-TCP/collagen scaffolds loaded with
fibroblast growth factor-2 (FGF-2) improved
periodontal tissue wound healing results
Chitosan, PLGA, and silver (Ag)
nanoparticles complex Xue et al. [22]
Contributed to cell mineralization without
cytotoxicity
GelMA/nHAmicrogels Chen et al. [37] Promoted in vivo osteogenesis of hPDLSCsencapsulated in microgels
nanomaterial-based silk fibroin scaffolds
incorporating BMP-7 and/or PDGF-ß Zhang et al. [103] Promoted periodontal healing
PCLpowder containing HA Rasperini et al. [104] Clinical study with failure due exposure ofthe scaffold
Graphene Xie et al. [112] Favourable on osteogenic differentiation butnot on osteoblastic differentiation
Graphene Oxide combined with silk
fibroin Rodríguez-Lozano et al. [65]
Favourable on mechanical resistance and
hPDLSC proliferation and showed
biocompatibility
Graphene Oxide combined with silk
fibroin Vera-Sánchez et al. [66]
PDLSC proliferation rate into
osteo/cementoblast like cells improved with
these combinations
GO-coating of titanium implants Ren et al. [67]
Improved cell proliferation, osteogenic
differentiation and biocompatibility of
implants
Citric Acid-Based Nano Hydroxyapatite Dayashankar et al. [39] Significant bone regeneration
Nano-bioactive glass loaded with
NELL1 gene Zhang et al. [31]
Good osteoconductivity for promoting the
formation of new alveolar bone tissue
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Table 1. Cont.
Material Reference Outcome
Poly(l-lactic acid) (PLLA) nanofibrous
spongy microspheres,
PLLA/polyethylene glycol (PEG)
co-functionalized mesoporous silica
nanoparticles, and poly(lactic
acid-co-glycolic acid) (PLGA)
microspheres
Liu et al. [23]
In a mouse model of periodontitis, the
injectable and biomolecule-delivering PLLA
lead to Treg enrichment, expansion, and
Treg-mediated immune therapy against
bone loss
Nanofibrous yarn reinforced HA-gelatin Manju et al. [34] Promoted bone formation in critical sizedalveolar defects in rabbit model
Silver nanoparticle-coated collagen
membrane Chen et al. [35]
Induced osteogenic differentiation of
mesenchymal stem cells that guide bone
regeneration.
Chitosan-gold nanoparticles mediated
gene delivery Takanche et al. [48]
Enchanced osseointegration of dental
implant even in osteoporotic condition
Hydroxyapatite nanowires modified
polylactic acid membrane Han et al. [36]
Promoted bone regeneration in a rat
mandible defect model
PCL/chitosan/Sr-doped calcium
phosphate electrospun nanocomposite Ye et al. [56]
Higher ALP activity level and a better
matrix mineralization
Nano hydroxyapatite mineralized silk
fibroin Nie et al. [38] Improved osteogenesis
PLGA/PCL Modification Including
Silver Impregnation, Collagen Coating,
and Electrospinning
Qian et al. [24] Enhanced alveolar bone regeneration(31.8%)
One of the limitations of the nanoscaffold systems is the incorporation of nanoscale material
for reinforcement. In the regeneration of bone, utilizing micro- and nano-length scale materials can
be beneficial for increasing the intrinsic fracture resistance of the bone by affecting bone strength
and supporting plasticity. However, macro-length scale materials are also beneficial, influencing
toughness and creating a resistance to fracture. In brief, nanoscale materials increase the capacity to
withstand pressure, but toughness drops dramatically [6] and it is not realistic to expect both high
strength and high toughness properties from one single material [113]. As an example, in ceramic
based materials, toughness is provided majorly by their large scales. Ceramic based materials are
able to shield crack by supporting uncracked material bridging the crack wake, which is impossible
for micro/nano-scale materials [114,115]. Nanotechnology alone cannot be the optimum solution for
improving the mechanical properties of the scaffolds. Incorporation of different scale materials with a
hierarchical design exhibiting many scales seems to be beneficial and should be considered as a future
perspective [6,116].
3. Conclusions
This review mainly focused on the basic information about the nanomaterials for bone regeneration
to give researchers a general knowledge about their possible applications in the oral field. Currently
their application in oral and maxillofacial clinics is very limited but interest is increasing for their
possible applications in order to overcome the current problems associated with conventional materials.
As a conclusion, it can be underlined that nanomaterials have excellent physico-chemical properties
and biomimetic features for promoting cell growth and stimulating tissue regeneration, and oral tissue
engineering with nanomaterials seems to represent a great potential with vital importance as future
treatment modalities.
However, nanomaterials should not be evaluated as optimum solutions for every current problem.
It should be understood that there are also disadvantages of nanomaterials such as toughness, which
can be solved with the incorporation of a hierarchical design encompassing many length-scales to
generate stronger and tougher scaffold materials. They can also provoke adverse events by moving
all over the body or by depositing in organs due to their nanosize, which is similar to biological
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molecules and viruses. Further research needs to be done in order to provide solutions for possible
future applications.
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Abbreviations
TE/RM Tissue engineering and regenerative medicine
GF Growth factors
BMP Bone morphogenetic proteins
mRNA Micro ribonucleic acid
TCP Tricalcium phosphate
BMMSC Bone marrow mesenchymal stem cells
MSC Mesenchymal stem cells
PRP Platelet rich plasma
ECM Extracellular matrix
nm Nanometers
µm Micrometers
NP Nanoparticles
PLA Poly-lactic acid
PGA Poly-glycolic acid,
PLGA Poly-lactic-co-glycolic acid
PLLA poly(l-lactic acid)
PEG PLLA/polyethylene glycol
PCL Poly-caprolactone
CP Calcium Phosphate
HA Hydroxyapatite
TCP Tricalcium phosphate
nHA Nano hydroxyapatite
nTCP Nano tricalcium phosphate
MTA Mineral trioxide aggregate
MSNP Mesoporous silica nanoparticle
CNT Carbon nanotube
GO Graphene oxide
CD Carbon dots
GO Graphene oxide
rGO Reduced graphene oxide
SLS Selective laser sintering
3D 3 dimensional
SMF Static magnetic field
FGF-2 Fibroblast growth factor-2
Ag Silver
GelMA Gelatin methacrylate
hPDLSC Human periodontal ligament stem cells
CEMP1 Cementum protein 1
PDGF Platelet derived growth factor
DNA Deoxyribonucleic acid
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